What is Woundtech?
Established in 1999, Woundtech has emerged as a leader in advanced, personalized mobile wound care. The company bridges the gap between complex clinical requirements and patient accessibility by deploying expert care teams to provide treatment in the home environment. With a track record of over 2 million patient encounters, the firm utilizes proprietary products and evidence-based methodologies to address chronic conditions. By partnering with insurance providers, Woundtech effectively integrates its services into the broader healthcare ecosystem, focusing on both clinical outcomes and the reduction of overall healthcare expenditures through a patient-centered model.
How much funding has Woundtech raised?
Woundtech has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2016): $40M with participation from Aldrich Capital Partners
Key Investors in Woundtech
Aldrich Capital Partners
Aldrich Capital Partners is a growth equity firm that supports founder-run companies by providing both capital and operational expertise to help businesses scale effectively.
What's next for Woundtech?
With the infusion of this major strategic investment, Woundtech is poised to accelerate its operational scaling and technological integration. The company's trajectory suggests a focus on deepening its partnerships with insurance payers to further standardize home-based wound care as a cost-effective alternative to traditional clinical settings. As the healthcare industry continues to shift toward value-based care, Woundtech's ability to address social drivers of health while maintaining high patient satisfaction scores will be critical. Future growth will likely involve the expansion of its proprietary product suite and the optimization of its mobile care delivery network to meet the rising demand for decentralized medical services.
See full Woundtech company page
